澳大利亚肺癌局限切除后再干预与生存分析
基于新南威尔士州住院与死亡登记联动数据,纳入2002年7月至2014年3月所有肺癌局限切除患者,采用竞争风险分析评估再干预风险与预测因素。5年总生存率52%,6个月和24个月再干预率分别为6.2%和11.3%,再干预与死亡风险增加约两倍相关。
要点
- 局限切除后6个月和24个月再干预率分别为6.2%和11.3%,医院间差异显著。
- 高手术量医院6个月内再干预风险降低49%(HR 0.30-0.85),24个月时效应减弱。
- 6个月或24个月内再干预分别与死亡风险增加约2倍和2.3倍相关。
核心结论
- 肺癌局限切除后再干预率适中但医院间差异大,再干预与更低生存相关。
研究设计与样本
- 基于人群的全包含研究,使用新南威尔士州住院患者数据收集与死亡登记联动数据,纳入2002年7月1日至2014年3月31日所有肺癌局限切除患者,采用单因素和多因素竞争风险分析。
主要发现
- 局限切除肺癌患者5年总生存率为52%(49%-54%),70岁及以上患者为44%(40%-47%)。
- 术后6个月再干预率6.2%,24个月为11.3%。
- 年轻、私立医院手术和合并症较少与再干预风险增加独立相关。
- 高手术量医院6个月内再干预风险降低49%(95%CI 0.30-0.85),24个月时风险比0.87(95%CI 0.60-1.28)。
- 6个月内再干预者死亡风险增加2倍(95%CI 1.52-2.57),24个月内再干预者增加2.3倍(95%CI 1.89-2.83)。
临床怎么用
- 局限切除后应关注再干预风险,尤其低手术量医院患者,再干预提示预后不良需加强随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To investigate the risk and predictors of reintervention (surgery or radiotherapy) after limited resection for lung cancer. METHODS: A population-based, all-inclusive study using linked data from the New South Wales Admitted Patient Data Collection and Death Register included all patients undergoing limited resection for lung cancer between July 1, 2002, and March 31, 2014. Univariate and adjusted competing risk analyses were used to estimate the effect of potential factors for risk of reintervention within 6 months and 24 months of the initial surgery. RESULTS: The overall 5-year survival for lung cancer patients undergoing limited lung resection was 52% (49% to 54%); for patients aged 70 years or more, the survival rate was 44% (40% to 47%). Reintervention occurred in 6.2% by 6 months and 11.3% by 24 months after the surgery. Younger age, surgery in private hospitals, and fewer comorbidities were independently associated with increased risk of reintervention. Patients who had the surgery performed in high surgical volume hospitals had 49% lower risk of reintervention within the first 6 months (95% confidence interval: 0.30 to 0.85). The effect of hospital surgical volume was attenuated by 24 months (hazard ratio 0.87, 95% confidence interval: 0.60 to 1.28). Patients undergoing reintervention within 6 months or 24 months had a twofold (1.52 to 2.57) and 2.3-fold (1.89 to 2.83) increased risk of death, respectively. CONCLUSIONS: The reintervention rate within 6 or 24 months of initial limited lung cancer resection was modest, but there was considerable variation among hospitals. Reintervention was not a benign event and was associated with lower survival in an Australian population.
引用
- Tran B, Sedrakyan A, Flynn P, et al. Reintervention and Survival After Limited Lung Resection for Lung Cancer Treatment in Australia. Ann Thorac Surg. 2018. PMID: 30579847. doi:10.1016/j.athoracsur.2018.11.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。